Showing reports 1 - 10 of 13 in category Nanomedicine:
| Cancer Nanotechnology Plan | |
| Source: NCI Alliance for Nanotechnology in Cancer – Publication date: July 2004 | |
 | The CNPlan describes how to accelerate the application of nanotechnology to cancer research and clinical care, emphasizing the need for cross-disciplinary and cross-sector collaboration to develop and deliver the public health benefits. |
| Cutting nature's building blocks down to size | |
| Source: TA Swiss – Publication date: December 2003 | |
 | Abridged version of the TA-SWISS (Switzerland's Center for Technology Assessment) Study "Nanotechnology in Medicine" |
| European Technology Platform on NanoMedicine | |
| Source: European Technology Platform NANOMEDICINE – Publication date: September 2005 | |
 | Vision Paper and Basis for a Strategic Research Agenda for NanoMedicine in Europe. This European Technology Platform addresses ambitious, responsible research, development and innovation in Nanotechnology for Health to strengthen the competitive scientific and industrial position of Europe in the area of NanoMedicine and improve the quality of life and health care of its citizens. |
| Impact of Nanotechnology in Health and Medical Systems | |
| Source: Nanoroadmap Project (NRM) – Publication date: December 2005 | |
 | A 10 year (2006-2015) technology roadmap for Nanomedicine in Europe with a focus on four topics: Drug encapsulation/ drug delivery/ drug targeting; Molecular Imaging/ Biophotonics; Biochips/ High-Throughput Screening/ Lab-on-a-chip technology; Biomolecular Sensors. |
| Nanomedicine Taxonomy | |
| Source: Canadian NanoBusiness Alliance – Publication date: February 2003 | |
 | This document presents a nanomedicine taxonomy that describes some of the principal areas of nanotechnology and related small technology activities currently being undertaken in medicine and health care. |
| Nanomedicine. An ESF-European Medical Research Councils (EMRC) Forward Look Report | |
| Source: European Science Foundation – Publication date: December 2005 | |
 | The report summarizes the results of a foresight study on developments in nanotechnologies for medical applications which was organised by ESF from 2003-2005. The study aimed to define the field; discuss the future impact of nanomedicine on healthcare practice and society; review the current state of the art of nanomedicines research; identify european strengths and weaknesses; deliver recommendations on future research trends, priorities for funding, the need for research infrastructure and how to communicate about it to the general public. |
| Nanomedicine: Nanotechnology for Health - Strategic Research Agenda | |
| Source: European Technology Platform NANOMEDICINE – Publication date: November 2006 | |
 | The European Technology Platform on NanoMedicine is an industry-led consortium, bringing together the key European stakeholders in the sector. In September 2005 it delivered a common vision of this technologically and structurally multi-faceted area, and defines the most important objectives in this Strategic Research Agenda. |
| Nanotechnology and its Implications for the Health of the EU Citizen | |
| Source: Nanoforum – Publication date: December 2003 | |
 | This report focuses on those areas in which nanotechnology is having a direct impact and includes diagnostics, drug discovery and delivery, surgery, tissue engineering and implants. |
| Nanotechnology in Medical Applications. State of the art in materials and devices | |
| Source: Department of Pharmaceutical Affairs and Medical Technology of the Dutch Ministry of Health, Welfare and Sports – Publication date: October 2005 | |
 | This report presents the state-of-the-art in the area of promising nanotechnology approaches for medical technology. In particular, relevant applications are reported in surgery, cancer diagnosis and therapy, biodetection of disease markers, molecular imaging, implant technology, tissue engineering, and devices for drug, protein, gene, and radionuclide delivery. |
| Nanotechnology in Medical Applications: Possible Risks for Human Health | |
| Source: Department of Pharmaceutical Affairs and Medical Technology of the Dutch Ministry of Health, Welfare and Sports – Publication date: October 2005 | |
 | This report recommends the development of specific guidance documents at a European level for the safety evaluation of nanotechnology products applied in medical technology is strongly recommended and the need for further research in the field of nanotoxicology is clearly identified. |
[First Page] [Prev] Showing page 1 of 2 pages [Next] [Last Page]
